Evidence map›Paper›PMID 30430372›Full record

Trial reportSleep & breathing = Schlaf & Atmung2019

Efficacy of vitamin D replacement therapy in restless legs syndrome: a randomized control trial.

Siraj Omar Wali, Bahaa Abaalkhail, Faris Alhejaili, S R Pandi-Perumal

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Sleep & breathing = Schlaf & Atmung, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02256215 (Vitamin D in the Treatment of Primary Restless Legs Syndrome), which is not on this map. Cited by 19 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 6 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02256215 phase2 / phase3unknown statusnot on this map

Vitamin D in the Treatment of Primary Restless Legs Syndrome: 12 Weeks, Triple-blinded, Randomized, Placebo-controlled Trial

TypeinterventionalSponsorKing Abdulaziz UniversityRan2015Enrolled106ConditionsRestless Legs SyndromeArmsVitamin D
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 6 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Vitamin D and Hyperkinetic Movement Disorders: A Systematic Review.Tremor and other hyperkinetic movements (New York, N.Y.) · 2020
    Pooled it
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Vitamin D deficiency and restless legs syndrome during pregnancy: walking in sunshine?Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
  12. Determination of optimal 25-hydroxyvitamin D cutoff values for the evaluation of restless legs syndrome among pregnant women.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023
    Article
  13. Vitamin D and Restless Legs Syndrome: A Review of Current Literature.Tremor and other hyperkinetic movements (New York, N.Y.) · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Siraj Omar WaliSleep Medicine Research Group, Sleep Medicine and Research Center, College of Medicine, King Abdulaziz University Hospital, P.O. Box 21589, Jeddah, 80215, Saudi Arabia. sowali@kau.edu.sa.ORCID http://orcid.org/0000-0002-5825-5642
Bahaa AbaalkhailFamily and Community Medicine Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Faris AlhejailiSleep Medicine Research Group, Sleep Medicine and Research Center, College of Medicine, King Abdulaziz University Hospital, P.O. Box 21589, Jeddah, 80215, Saudi Arabia.
S R Pandi-PerumalSomnogen Canada Inc., College Street, Toronto, ON, Canada.
King Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRestless legs syndrome is a movement sleep disorder that may be linked to dopaminergic dysfunction and in which vitamin D may play a role. This 12-week randomized, placebo-controlled trial elucidated the efficacy of vitamin D supplements in decreasing restless legs syndrome symptom severity.

methodsThirty-five subjects with restless legs syndrome, diagnosed using the International Restless Legs Syndrome Study Group criteria, were enrolled. The subjects were randomized to orally receive either vitamin D (50,000 IU caplets) or a placebo. All medications were administered weekly using a direct observation technique. Clinical assessments, including those for restless legs syndrome severity, were conducted at baseline and the end of the study using the International Restless Legs Syndrome Study Group rating scale. The serum vitamin D levels and bone profiles were measured at baseline and every 4 weeks. The primary endpoint was the change in the restless legs syndrome severity score from baseline to week 12. There were 17 and 18 patients in the vitamin D and placebo groups, respectively.

resultsThe groups did not differ with respect to age, sex, restless legs syndrome severity, or vitamin D levels. Participants in the vitamin D group showed no significant change in the mean restless legs syndrome severity score compared with the placebo group.

conclusionsThe results suggest that vitamin D supplementation does not improve restless legs syndrome symptoms. CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov : NCT02256215 (available from: https://clinicaltrials.gov/ct2/show/NCT02256215 ).

Indexed as

Administration, OralAdultCorpus StriatumDopamineDouble-Blind MethodFemaleHumansMaleMiddle AgedPrevalenceRestless Legs SyndromeSaudi ArabiaSubstantia NigraTreatment FailureVitamin DDopamineVitamin DPrimaryRestless legs syndromeRLSScaleSymptomsVitamin D

Identifiers

PMID30430372
OpenAlexW2900581784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.